PortfoliosLab logoPortfoliosLab logo
INTC vs. PFE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INTC vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intel Corporation (INTC) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INTC achieves a 168.75% return, which is significantly higher than PFE's 8.09% return. Over the past 10 years, INTC has outperformed PFE with an annualized return of 14.49%, while PFE has yielded a comparatively lower 2.09% annualized return.


INTC

1D
-11.28%
1M
-12.25%
YTD
168.75%
6M
139.48%
1Y
396.10%
3Y*
48.40%
5Y*
13.56%
10Y*
14.49%

PFE

1D
1.36%
1M
-0.23%
YTD
8.09%
6M
3.39%
1Y
20.50%
3Y*
-6.48%
5Y*
-2.98%
10Y*
2.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INTC vs. PFE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INTC
Intel Corporation
168.75%84.04%-59.57%94.56%-46.64%6.05%-14.69%30.71%4.23%30.87%
PFE
Pfizer Inc.
8.09%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%

Correlation

The correlation between INTC and PFE is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Mar 18, 1980

0.28

The correlation between INTC and PFE shifts across timeframes, from 0.14 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

INTC:

$504.08B

PFE:

$149.24B

EPS

INTC:

-$0.67

PFE:

$1.31

PS Ratio

INTC:

8.69

PFE:

2.35

PB Ratio

INTC:

4.53

PFE:

1.66

Total Revenue (TTM)

INTC:

$53.76B

PFE:

$63.32B

Gross Profit (TTM)

INTC:

$19.05B

PFE:

$43.91B

EBITDA (TTM)

INTC:

$8.83B

PFE:

$16.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INTC vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INTC
INTC Risk / Return Rank: 9898
Overall Rank
INTC Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
INTC Sortino Ratio Rank: 9797
Sortino Ratio Rank
INTC Omega Ratio Rank: 9696
Omega Ratio Rank
INTC Calmar Ratio Rank: 9999
Calmar Ratio Rank
INTC Martin Ratio Rank: 9898
Martin Ratio Rank

PFE
PFE Risk / Return Rank: 6767
Overall Rank
PFE Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6464
Sortino Ratio Rank
PFE Omega Ratio Rank: 6161
Omega Ratio Rank
PFE Calmar Ratio Rank: 7272
Calmar Ratio Rank
PFE Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INTC vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intel Corporation (INTC) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INTCPFEDifference
Sharpe ratioReturn per unit of total volatility

+4.62

Sortino ratioReturn per unit of downside risk

+3.32

Omega ratioGain probability vs. loss probability

1.60

1.17

+0.43

Calmar ratioReturn relative to maximum drawdown

16.52

1.79

+14.72

Martin ratioReturn relative to average drawdown

39.16

3.68

+35.48

INTC vs. PFE - Sharpe Ratio Comparison

The current INTC Sharpe Ratio is 5.48, which is higher than the PFE Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of INTC and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INTCPFEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

5.48

0.86

+4.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.26

-0.12

+0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.33

0.09

+0.24

Sharpe Ratio (All Time)

Calculated using the full available price history

0.35

0.33

+0.02

Drawdowns

INTC vs. PFE - Drawdown Comparison

The maximum INTC drawdown since its inception was -82.25%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for INTC and PFE.


Loading charts...

Drawdown Indicators


INTCPFEDifference

Max Drawdown

Largest peak-to-trough decline

-82.25%

-69.24%

-13.01%

Max Drawdown (1Y)

Largest decline over 1 year

-24.17%

-11.47%

-12.70%

Max Drawdown (3Y)

Largest decline over 3 years

-63.80%

-40.75%

-23.05%

Max Drawdown (5Y)

Largest decline over 5 years

-65.95%

-58.96%

-6.99%

Max Drawdown (10Y)

Largest decline over 10 years

-70.80%

-58.96%

-11.84%

Current Drawdown

Current decline from peak

-23.39%

-46.03%

+22.64%

Average Drawdown

Average peak-to-trough decline

-36.67%

-22.89%

-13.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.18%

5.59%

+4.59%

Volatility

INTC vs. PFE - Volatility Comparison

Intel Corporation (INTC) has a higher volatility of 24.54% compared to Pfizer Inc. (PFE) at 4.50%. This indicates that INTC's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INTCPFEDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.54%

4.50%

+20.04%

Volatility (6M)

Calculated over the trailing 6-month period

57.45%

14.66%

+42.79%

Volatility (1Y)

Calculated over the trailing 1-year period

72.88%

23.92%

+48.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.80%

25.50%

+26.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.91%

23.88%

+20.03%

Dividends

INTC vs. PFE - Dividend Comparison

INTC has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.61%.


PositionTTM20252024202320222021202020192018201720162015
INTC
Intel Corporation
0.00%0.00%1.87%1.47%5.52%2.70%2.65%2.11%2.56%2.33%2.87%2.79%
PFE
Pfizer Inc.
6.61%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%

Financials

INTC vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Intel Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B20222023202420252026
13.58B
14.45B
(INTC) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

INTC vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Intel Corporation and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
39.4%
67.3%
Portfolio components
INTC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a gross profit of 5.35B and revenue of 13.58B. Therefore, the gross margin over that period was 39.4%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

INTC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported an operating income of -3.14B and revenue of 13.58B, resulting in an operating margin of -23.1%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

INTC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a net income of -3.73B and revenue of 13.58B, resulting in a net margin of -27.5%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.


Frequently Asked Questions


INTC and PFE have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INTC has higher volatility (24.54%) compared to PFE (4.50%). In terms of maximum drawdown, INTC dropped -82.25% vs PFE's -69.24%.

INTC currently has the higher Sharpe Ratio (5.48 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INTC and PFE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer